Literature DB >> 32914978

Therapeutic Exploitation of GPR18: Beyond the Cannabinoids?

Paula Morales1, Ana Lago-Fernandez1, Dow P Hurst2, Noori Sotudeh2, Eugen Brailoiu3, Patricia H Reggio2, Mary E Abood3, Nadine Jagerovic1.   

Abstract

GPR18 is a G-protein-coupled receptor that belongs to the orphan class A family. Even though it shares low sequence homology with the cannabinoid receptors CB1R and CB2R, a growing body of research suggests its relationship with the endocannabinoid system, not only because it is able to recognize cannabinoid ligands but also because of its expression and ability to heteromerize with CBRs. In this review, we aim to analyze the biological relevance, reported modulators, and structural features of GPR18. In order to guide future drug design in this field, highlights from molecular modeling of GPR18 will be provided.

Entities:  

Year:  2020        PMID: 32914978     DOI: 10.1021/acs.jmedchem.0c00926

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment-Resistant Epilepsy.

Authors:  Brittney H Davis; T Mark Beasley; Michelle Amaral; Jerzy P Szaflarski; Tyler Gaston; Leslie Perry Grayson; David G Standaert; E Martina Bebin; Nita A Limdi
Journal:  Clin Pharmacol Ther       Date:  2021-09-22       Impact factor: 6.903

Review 2.  Targeting the Endocannabinoidome in Pancreatic Cancer.

Authors:  Valerio Falasca; Marco Falasca
Journal:  Biomolecules       Date:  2022-02-17

Review 3.  Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson's Disease.

Authors:  Felipe Patricio; Alan Axel Morales-Andrade; Aleidy Patricio-Martínez; Ilhuicamina Daniel Limón
Journal:  Front Pharmacol       Date:  2020-12-15       Impact factor: 5.810

4.  Identification of Immune-Related Genes in Sepsis due to Community-Acquired Pneumonia.

Authors:  Yanyan Li; Jiqin Wang; Yuzhen Li; Chunyan Liu; Xia Gong; Yifei Zhuang; Liang Chen; Keyu Sun
Journal:  Comput Math Methods Med       Date:  2021-08-26       Impact factor: 2.238

Review 5.  "The Two Sides of the Same Coin"-Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained.

Authors:  Mona Khoury; Idan Cohen; Gil Bar-Sela
Journal:  Pharmaceutics       Date:  2022-02-10       Impact factor: 6.321

6.  Targeting CB2 and TRPV1: Computational Approaches for the Identification of Dual Modulators.

Authors:  Paula Morales; Chanté Muller; Nadine Jagerovic; Patricia H Reggio
Journal:  Front Mol Biosci       Date:  2022-02-25

Review 7.  Why Do Marijuana and Synthetic Cannabimimetics Induce Acute Myocardial Infarction in Healthy Young People?

Authors:  Jolanta Weresa; Anna Pędzińska-Betiuk; Krzysztof Mińczuk; Barbara Malinowska; Eberhard Schlicker
Journal:  Cells       Date:  2022-03-28       Impact factor: 6.600

8.  Structure Prediction, Evaluation, and Validation of GPR18 Lipid Receptor Using Free Programs.

Authors:  Ilona Michalik; Kamil J Kuder; Katarzyna Kieć-Kononowicz; Jadwiga Handzlik
Journal:  Int J Mol Sci       Date:  2022-07-18       Impact factor: 6.208

9.  WIN55212-2 Modulates Intracellular Calcium via CB1 Receptor-Dependent and Independent Mechanisms in Neuroblastoma Cells.

Authors:  Victor M Pulgar; Allyn C Howlett; Khalil Eldeeb
Journal:  Cells       Date:  2022-09-21       Impact factor: 7.666

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.